Analysts Stocks

      Wells Fargo raises HCAT target to $1.75, stays Equal-Weight

      Stan Berenshteyn at Wells Fargo lifted their price target on HCAT to $1.75 on June 26, rating held at Equal-Weight.

      Stan’s record on HCAT: 18 calls tracked, the stock touching the target in 5 of 18 of them.

      The rating count on HCAT runs 5 Buy, 6 Hold right now. BTIG‘s David Larsen holds the high end of the range at $10; Stephens‘s Jeff Garro anchors the low end at $1.75. HCAT last closed at $2.24.

      HCAT price target chart: Wells Fargo raises to $1.75
      Stan Berenshteyn’s HCAT target history against the street high, street low and the stock price. Each dot marks a dated call.

      The $1.75 target is 22% below the stock’s $2.24 close.

      FAQ

      What is Wells Fargo’s price target on HCAT?

      Wells Fargo’s Stan Berenshteyn has a $1.75 target on HCAT, rated Equal-Weight, set June 26, 2026.

      How often have Stan Berenshteyn’s HCAT price targets been reached?

      AnaChart has tracked 18 price-target calls from Stan Berenshteyn on HCAT; the stock reached the target in 5 of them (28%).

      What is the analyst view on HCAT?

      Coverage is split 5 Buy / 6 Hold / 0 Sell, with targets from $1.75 (Stephens) to $10 (BTIG).